FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | N209482 | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED et al v. TRANSPIRE BIO INC. 4 patentsANDA 221261fluticasone furoate, umeclidinium, vilanterol | S.D. Fla. | 2026-06-16 | Active | — |
GlaxoSmithKline Intellectual Property Development Limited et al v. Transpire Bio Inc. 5 patentsANDA 220811fluticasone furoate, umeclidinium, vilanterol | S.D. Fla. | 2026-03-06 | Terminated 2026-03-10 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).